Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of treating inflammatory and autoimmune diseases with natalizumab

Methods of treating inflammatory and autoimmune diseases with natalizumab

US Patent 11333670 · Granted May 17, 2022

Estimated economic value: $67,292,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Administration of agents for the treatment of inflammation2022
Anti-Laminin4 antibodies specific for LG4-52021
Anti-laminin4 antibodies specific for LG4-52020
Anti-MCAM antibodies and associated methods of use2020
Methods of treating inflammatory and autoimmune diseases with natalizumab2019
Anti-MCAM antibodies and associated methods of use2019
Anti-MCAM antibodies and associated methods of use2019
Anti-Laminin4 antibodies specific for LG4-52018
Anti-MCAM antibodies and associated methods of use2016
Prevention and treatment of amyloidogenic disease2014
Multimeric VLA-4 antagonists comprising polymer moieties2012
Prevention and treatment of amyloidogenic disease2011